Nobody embodies the EU’s elite-driven nature better than its incumbent president, Ursula von der Leyen. And no action of hers embodies its warped excesses better than her decision, in April 2021, to single-handedly sign off on a €35-billion deal for the purchase of 1.8 billion doses of the BioNTech/Pfizer vaccine. According to one analysis, the price per dose she agreed was 15 times higher than the cost of production — meaning that the EU overpaid the vaccines by tens of billions of euros.
Related Articles
Climate Crisis
The New Green Deal Group: How to Pay for the Green New Deal: A Briefing
December 4, 2019
Mathew D. Rose
Climate Crisis, Finance, Green New Deal, Solutions, Sustainability
0
Debate in the 2019 election campaign in the UK has focussed on whether spending plans proposed by political parties are affordable. This, the Group argues, is to fundamentally misunderstand the way that government investment works. […]
Environment
Anna Lappé: Follow the Money to the Amazon
Who is profiting from the development that led to these fires? Read here
National Politics
Middle East Eye: Refugees in Libya forced to return home or risk torture, UN report finds
Libyan authorities face mounting criticism over systematic human rights violations in their treatment of refugees Read Here Refugees at a detention centre in Tripoli, Libya

Be the first to comment